
Nā Nūhou Hou loa: Hoʻopau ʻo IL-4 i ka pau ʻana o nā Pūnaewele CD8+ CART

Nūhou| ʻO ka hoʻohui ʻana-hoʻoholo ʻana i ka ʻāpana Clustering hiki ke hoʻopau i ka CAR-T Cell Dysfunction

ʻO ke kaʻina hana ʻo Sanger vs. Ke Kaʻina Hana Hou (NGS)
Ke hoʻololi nei ʻo Alpha Lifetech Incorporation i ke kahua o ka biotechnology ma o ka hāʻawi ʻana i nā lawelawe piha i luna a me lalo i hoʻohālikelike ʻia no nā protein recombinant. Me ka manaʻo nui i ka hāʻawi ʻana i nā kumuwaiwai protein kiʻekiʻe, manaʻo ʻo Alpha Lifetech e hoʻopololei i nā kaʻina noiʻi a me ka hoʻomohala ʻana no nā ʻoihana biopharmaceutical. Ma ka hāʻawi ʻana i nā hoʻonā hou e hoʻokō i nā pono kikoʻī o ka ʻoihana, hōʻoia ka hui i ka hana kūpono a me ka hoʻomaʻemaʻe ʻana i nā protein. Hoʻonui kēia hana i ka hiki o nā ʻepekema a me nā mea noiʻi a me nā kūlana Alpha Lifetech ma ke ʻano he alakaʻi i ka ʻāpana biotechnology. Me ka hoʻokō i ka holomua ʻana i nā ʻenehana protein, ua mākaukau ʻo Alpha Lifetech Incorporation e hana i nā haʻawina nui i nā holomua ʻepekema a me nā hoʻomohala therapeutic.

Nā alakaʻi alakaʻi no ka hoʻomaʻemaʻe ʻana i ka protein: nā ʻano, nā ʻenehana, a me nā noi
Ua hoʻolaha ʻo Alpha Lifetech Incorporation i kahi loiloi piha o ka hoʻomaʻemaʻe protein, kahi hana koʻikoʻi i ke kaʻina hana protein. Hāʻawi ka loiloi i nā ʻike koʻikoʻi a me nā mea koʻikoʻi no nā hoʻokolohua ma hope a me ka noiʻi ʻana ma ke kahua o ka hoʻomaʻemaʻe protein. Manaʻo ʻia kēia loiloi e kōkua nui i ka holomua o ka hana protein a me ka hoʻomohala ʻana i nā pahuhopu therapeutic hou. ʻIke ʻia ʻo Alpha Lifetech Incorporation no kona akamai i ka hana biopharmaceutical a ua kūpaʻa ʻo ia i ka hāʻawi ʻana i nā hopena ʻokiʻoki no ka hoʻomaʻemaʻe protein. Manaʻo ʻia kēia loiloi e loaʻa ka hopena nui i ka ʻoihana a hoʻopaʻa i ke kūlana o Alpha Lifetech ma ke ʻano he alakaʻi i ka noiʻi biopharmaceutical a me ka hoʻomohala ʻana.

Nūhou Hou| Hōʻike ka noiʻi hou i ka hiki ke hoʻohuli i ka make maʻi maʻi
Ma Iune 1, 2024, ma ka puke pai Nature Communications, ua paʻi nā ʻepekema mai ka hui noiʻi o Bo Li i kahi ʻatikala i kapa ʻia ʻo "Area postrema neurons mediate interleukin-6 function in cancer cachexia". Ua ʻike ʻia ka ʻatikala ʻo ka piʻi ʻana o ka interleukin-6 hiki ke alakaʻi i ka hana ʻino o ka lolo a me ka maʻi maʻi cachexia.

Nūhou Hou | Hāʻawi kahi mea hoʻokae koho mua o ka EGFR a me PI3K i kahi ala hoʻokahi-molecule i ka hoʻopaʻa ʻana i ke kū'ē kūpono.
Ma Iulai 11, 2024, ua hoʻolālā kahi hui o nā mea noiʻi i alakaʻi ʻia e Dr. Judith Sebolt Leopold i kahi mea hoʻopaneʻe kinase MTX-531 hiki ke pale i ka epidermal growth factor receptor (EGFR) a me ka phosphatidylinositol 3-OH kinase (PI3K).

Hoʻoikaika i ka ʻike ʻana i ka lāʻau lapaʻau me nā Antibodies Biosimilar - ʻO ke ala wikiwiki i ka hoʻopaʻa ʻana
ʻO Alpha Lifetech's 700+ biosimilar antibodies i hoʻopaʻa ʻia ʻo EGFR, TNF-α, VEGF, e wikiwiki ana i ka noiʻi lāʻau me ka maikaʻi i hōʻoia ʻia.

Wehe i nā mea pohihihi o nā kaʻina hana olaola: Hoʻopuka ʻo Alpha Lifetech i nā protein membrane kiʻekiʻe no nā ʻepekema.
Hāʻawi ʻo Alpha Lifetech i nā protein membrane maikaʻi no ka ʻike ʻana i ka lāʻau a me nā ʻike kelepona, me ka hoʻohana ʻana i nā ʻenehana hana kiʻekiʻe.

ʻO ka Art a me ka ʻepekema o Nanobody Discovery: Pehea ʻo Alpha Lifetech e hoʻokau nei i nā palena
E ʻike i ka ʻenehana nanobody: ka hōʻike phage, ka pale ʻana, ka nānā ʻana, ke koho ʻana, a me ka nānā ʻana i ke kūkulu ʻana ma Alpha Lifetech no ka diagnostics a me ka lāʻau lapaʻau.